There has been considerable discussion around the concept of patientcentricity in the pharmaceutical community. The industry has taken a collective pause in an effort to …
Where information overload has started to slow innovation and efficiency in medicinal markets, could artificial intelligence and machine learning help – by pinpointing what’s important …
The healthcare industry needs a fully connected IT infrastructure, integrating information from multiple systems to ease administrative workloads, facilitate patient-provider collaboration, and improve quality of …
Pharmaceutical companies have been working for years on leveraging their clinical research data in more efficient ways, but other sectors of the research industry have …
In this paper, Chris Hamilton, Chief Commercial Officer at CROS NT, analyses how it is important to delve into the challenges when trying to achieve …
In this paper, Laure Lam Hung PhD, Project Manager and Clinical Research Associate at CIDP and Dr Tarkeswarnath Bachoo MBBS, MD (Paediatrics), Consultant Paediatrician at …
The US Food and Drug Administration (FDA) allows for some flexibility related to changes in clinical trial protocols—for example, with adaptive trials. However, certain changes …
Immunostimulating interstitial laser thermotherapy (imILT) is a treatment protocol for solid tumours developed to destroy the tumour at the treatment site while simultaneously inducing an …
In industry-sponsored clinical trials, as the sponsors are for-profit companies, contract negotiations with the trial sites can be difficult and complex. The smooth management of …
More than six years have passed since the federal law ‘On Circulation of Medicines’ came into effect, replacing the law ‘On Medicines’. The adoption of …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
